Other
698 A.2d 959 (Del. Ch. 1996)
Study notes for In re Caremark International Inc. Derivative Litigation: professor notes, cold call prep, exam angles, and memory aids.
Directors are not liable for failure to oversee compliance unless there is clear evidence of bad faith.
In Caremark, the court tackled the critical issue of director oversight and the standards required to meet fiduciary duties in managing corporate compliance. A key takeaway is that while the failure to implement a comprehensive compliance program was noted, the directors did not act in bad faith, which is a necessary element to establish a breach of fiduciary duty. This case sets a nuanced precedent regarding the obligations of boards, highlighting that some level of compliance oversight can absolve directors from liability even if it falls short of the ideal. Professors often emphasize the implications for corporate governance that arise from Caremark's holding and the importance of distinguishing mere negligence from a lack of good faith in these fiduciary contexts.
Caremark Compliance Cultivates Careful Directors.
| Case | Distinction |
|---|---|
| Smith v. Van Gorkom | In Smith, directors were found liable for gross negligence in their decision-making, demonstrating a stark contrast with Caremark's emphasis on bad faith and compliance oversight. |
| In re Citigroup Inc. Shareholder Derivative Litigation | The Citigroup case further develops the Caremark standard by addressing the consequence of inaction leading to significant corporate harm, whereas Caremark focused more on the lack of bad faith. |
Supporters argue that allowing directors to avoid liability promotes a more pragmatic approach to oversight, encouraging reasonable, good faith efforts without imposing draconian standards.
Critics suggest that the ruling may enable insufficient oversight and neglect of duty, potentially leading to significant corporate failures and shareholder harm.
Exams may test your understanding of fiduciary duties and the standards for board oversight, particularly the distinction between negligence and bad faith. Students should be prepared to analyze how Caremark fits into the larger framework of corporate governance.